TransGenRx
Baton Rouge
About TransGenRx
TransGenRx, a biopharmaceutical manufacturing company, has developed technology that significantly reduces the cost of producing protein-based drugs by using a high expressing avian cell line combined with their patented vector system. Patented and patent pending processes allow TGRx to develop custom proteins to meet a wide range of specifications. Use the links on the left to learn more about our team as well as the products and services we offer through our patent and patent pending technologies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.9M
- Last round: Series Unknown (Oct 2010)
- Website: tgrxinc.com
- Phone: +1 (888) 432-0721
Industries & Categories
Biopharma, Biotechnology, Manufacturing
Canonical: https://fsome.com/organization/transgenrx-3443545 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.